BASILEA PHARMACEUTICA AG BAS (BPMUF)

Overview Price 39.50 Price Change Today 0.00 (0.00%) P&P rating Zacks Rank 2 - BUY Open Price $0.00 Previous Close $39.50 Daily Range $0.00 - $0.00 52-Week Range $33.80 - $83.68 Volume 0 BASILEA PHARMACEUTICA LTD. is headquartered in Basel, Switzerland, and listed on the SWX Swiss Exchange. Basilea's integrated research and development operations are currently focused on new antibacterial and antifungal agents to fight drug resistance and on the development of dermatology drugs. Basilea's products are targeted to satisfy high medical and patient needs in the hospital and specialty care setting. The company owns a diversified portfolio including two drugs under regulatory review (ceftobiprole and alitretinoin) and one phase-III investigational drug (isavuconazole). The company is currently building its sales and marketing organization to commercialize alitretinoin and to co-promote ceftobiprole in North America and major European countries, subject to approval. Other Resources for BPMUF Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary No Commentary Found for This Ticker. BASILEA PHARMACEUTICA LTD. is headquartered in Basel, Switzerland, and listed on the SWX Swiss Exchange. Basilea's integrated research and development operations are currently focused on new antibacterial and antifungal agents to fight drug resistance and on the development of dermatology drugs. Basilea's products are targeted to satisfy high medical and patient needs in the hospital and specialty care setting. The company owns a diversified portfolio including two drugs under regulatory review (ceftobiprole and alitretinoin) and one phase-III investigational drug (isavuconazole). The company is currently building its sales and marketing organization to commercialize alitretinoin and to co-promote ceftobiprole in North America and major European countries, subject to approval.   Brokerage Analyst Recommendations 2 Brokerage Firms Covering BPMUF   Strong Buy 0 Buy 0 Hold 2 Sell 0 Strong Sell 0 Average Broker Recommendation (ABR): 3   BPMUF Ratings: BUY  SELL  HOLD BPMUF Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 0 Buy 0 Sell   Top Buy Analysis No Buy Analysis. Be the First. More Recent Analysis Top Sell Analysis No Sell Analysis. Be the First. More Recent Analysis

Blog Posts

No related Blog Posts.

Commentary

There are no open picks with this stock at the moment.

Picks

There are no open picks with this stock at the moment.